InvestorsHub Logo
Post# of 4967551
Next 10
Followers 613
Posts 50771
Boards Moderated 1
Alias Born 01/22/2006

Re: None

Wednesday, 10/18/2006 7:01:16 PM

Wednesday, October 18, 2006 7:01:16 PM

Post# of 4967551
check this out folks, XECHEM (XKEM) is into more than just SCD drugs, how about chemotherapy as starters!

Paclitaxel is in a class of drugs known as taxanes. It slows or stops the growth of cancer cells in your body. The length of treatment depends on the types of drugs you are taking, how well your body responds to them, and the type of cancer you have

Focus on Select Global Players within the Bulk Paclitaxel Market with Annual Forecasts from 2000 Through to 2010 18 Oct 2006 13:12 GMT
... (USA), Inc (USA) - Taxolog, Inc (USA) - Teva Pharmaceutical Industries Ltd (Israel) - Xechem International, Inc (USA) - Xian Tiancheng Drugs & Bioengineering Co, Ltd (China) Research and ...

This report analyzes the worldwide markets for Bulk Paclitaxel in kilograms and US$ Million. The report provides separate comprehensive analytics for the US, and Rest of World. Annual forecasts are provided for the period of 2000 through 2010. The report profiles 31 companies including many key and niche players worldwide such as Abraxis BioScience, Inc., Bioxel Pharma, Inc., Bristol-Myers Squibb Co., Indena SpA, Mayne Pharma Limited, Mylan Laboratories, Inc., Sonus Pharmaceuticals, TEVA Pharmaceutical Industries Ltd, IVAX Corporation, and Xechem International, Inc. market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

"God Bless America our Troops and our Children"......... don't forget to, Let Freedom Ring!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.